Status:

COMPLETED

Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke

Lead Sponsor:

Manipal Acunova Ltd.

Collaborating Sponsors:

Ministry of Science and Technology, India

Conditions:

Acute Stroke

Eligibility:

All Genders

18-70 years

Phase:

PHASE2

Brief Summary

A multi-centric initiative to study safety,feasibility and efficacy of using intravenous autologous bone marrow mononuclear cells(BMMC) in patients with acute ischemic stroke.This phase of study is vi...

Detailed Description

This phase of the study will have two arms developed through random allocation: one arm for intravenous autologous bone marrow derived stem cell/mononuclear cells(BMMC arm); and second control arm. Pa...

Eligibility Criteria

Inclusion

  • Sudden onset of focal neurologic deficit or impairment of consciousness.
  • CT or MRI scan of head showing no haematoma and relevant lesions within the MCA and ACA territory.
  • Age between 30 -70 years (after amendment 18 -70 years).
  • \>7 to \</=30 days passed since the onset of the qualifying event.
  • Glasgow Coma Scale score of \>8 at the time of randomization, in aphasic Eye and Motor score of \>6.
  • Modified Barthel Index score of 50 or less at the time of randomization.
  • NHISS score of 7 or more points and inability to walk unaided or raise upper limb by 90 degree.
  • Patient is stable. ( normal respiration, afebrile, BP less than mean arterial pressure of 125 mm of Hg, fasting blood sugar \< 200 mg% and normal urea/electrolytes for at least 48 hours.)

Exclusion

  • Lacunar syndrome
  • Intubation
  • Posterior circulation stroke
  • Co morbidity likely to limit survival to less than 3 years eg. Hepatic or renal failure.
  • Inaccessibility for follow up.
  • Allergy to local anaesthetic.
  • Unwillingness to provide written informed consent.
  • Symptom of acute myocardial infarction or acute involvement of any other organ.
  • Pregnancy 10. HIV positive 11. Patient is a part of any other trial in last 6 months.

Key Trial Info

Start Date :

October 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2011

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT01501773

Start Date

October 1 2008

End Date

October 1 2011

Last Update

December 29 2011

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Post Graduate Institute of Medical Education and Research

Chandīgarh, Haryana, India, 160012

2

Armed Forces Medical College

Pune, Maharashtra, India, 411040

3

All India Institute of Medical Sciences

New Delhi, National Capital Territory of Delhi, India, 110029

4

Army Hospital (R & R Hospital)

New Delhi, National Capital Territory of Delhi, India